Evidence map›Paper›PMID 35523520›Full record

SynthesisRMD open2022

Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases.

Andréa Marques, Philipp Bosch, Annette de Thurah, Yvette Meissner, Louise Falzon, Chetan Mukhtyar, Johannes Wj Bijlsma, Christian Dejaco, Tanja A Stamm, EULAR task force on Points to Consider for the for remote care in rheumatic and musculoskeletal diseases

Abstract readSystematic Review
In one paragraph

Synthesis in RMD open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andréa Marques *Higher School of Nursing of Coimbra Health Sciences Research Unit Nursing, Coimbra, Portugal andreamarques23@esenfc.pt.ORCID 0000-0002-2026-9926
Philipp Bosch *Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0002-6783-6422
Annette de ThurahRheumatology, Aarhus University Hospital, Århus N, Denmark.ORCID 0000-0003-0103-4328
Yvette MeissnerEpidemiology and Health Services Research, German Rheumatism Research Centre, Berlin, Germany.ORCID 0000-0003-0147-4112
Louise FalzonHealth Economics and Decision Science, The University of Sheffield, Sheffield, UK.ORCID 0000-0002-9449-6056
Chetan MukhtyarVasculitis Service, Rheumatology Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.ORCID 0000-0002-9771-6667
Johannes Wj BijlsmaRheumatology, University Medical Center Utrecht Department of Rheumatology and Clinical Immunology, Utrecht, The Netherlands.ORCID 0000-0002-0128-8451
Christian DejacoRheumatology, Medical University of Graz, Graz, Austria.ORCID 0000-0002-0173-0668
Tanja A StammSection for Outcomes Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-3073-7284
EULAR task force on Points to Consider for the for remote care in rheumatic and musculoskeletal diseases

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo perform a systematic literature review (SLR) on different outcomes of remote care compared with face-to-face (F2F) care, its implementation into clinical practice and to identify drivers and barriers in order to inform a task force formulating the EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases (RMDs).

methodsA search strategy was developed and run in Medline (PubMed), Embase and Cochrane Library. Two reviewers independently performed standardised data extraction, synthesis and risk of bias (RoB) assessment.

resultsA total of 2240 references were identified. Forty-seven of them fulfilled the inclusion criteria. Remote monitoring (n=35) was most frequently studied, with telephone/video calls being the most common mode of delivery (n=30). Of the 34 studies investigating outcomes of remote care, the majority addressed efficacy and user perception; 34% and 21% of them, respectively, reported a superiority of remote care as compared with F2F care. Time and cost savings were reported as major benefits, technical aspects as major drawback in the 13 studies that investigated drivers and barriers of remote care. No study addressed remote care implementation. The main limitation of the studies identified was the heterogeneity of outcomes and methods, as well as a substantial RoB (50% of studies with high RoB).

conclusionsRemote care leads to similar or better results compared with F2F treatment concerning efficacy, safety, adherence and user perception outcomes, with the limitation of heterogeneity and considerable RoB of the available studies.

Indexed as

Musculoskeletal DiseasesHumansautoimmune diseasespatient care teampatient reported outcome measures

Identifiers

PMID35523520
PMCPMC9083395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.